These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 30881284)

  • 1. Iron in Neurodegeneration - Cause or Consequence?
    Ndayisaba A; Kaindlstorfer C; Wenning GK
    Front Neurosci; 2019; 13():180. PubMed ID: 30881284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration.
    Villalón-García I; Povea-Cabello S; Álvarez-Córdoba M; Talaverón-Rey M; Suárez-Rivero JM; Suárez-Carrillo A; Munuera-Cabeza M; Reche-López D; Cilleros-Holgado P; Piñero-Pérez R; Sánchez-Alcázar JA
    Neural Regen Res; 2023 Jun; 18(6):1196-1202. PubMed ID: 36453394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Aging of Iron Man.
    Ashraf A; Clark M; So PW
    Front Aging Neurosci; 2018; 10():65. PubMed ID: 29593525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.
    Bergsland N; Tavazzi E; Schweser F; Jakimovski D; Hagemeier J; Dwyer MG; Zivadinov R
    CNS Drugs; 2019 Nov; 33(11):1073-1086. PubMed ID: 31556017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron metabolism in Parkinsonian syndromes.
    Berg D; Hochstrasser H
    Mov Disord; 2006 Sep; 21(9):1299-310. PubMed ID: 16817199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Iron Accumulation in Atypical Parkinsonian Syndromes:
    Lee JH; Lee MS
    Front Neurol; 2019; 10():74. PubMed ID: 30809185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System.
    Joppe K; Roser AE; Maass F; Lingor P
    Front Neurosci; 2019; 13():15. PubMed ID: 30723395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of iron in neurodegenerative diseases.
    Li K; Reichmann H
    J Neural Transm (Vienna); 2016 Apr; 123(4):389-99. PubMed ID: 26794939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Iron accumulation and neurodegenerative diseases].
    Yoshida K
    Nihon Rinsho; 2016 Jul; 74(7):1161-7. PubMed ID: 27455807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.
    Weinreb O; Mandel S; Youdim MBH; Amit T
    Free Radic Biol Med; 2013 Sep; 62():52-64. PubMed ID: 23376471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: iron metabolism and the role of iron in neurodegenerative disorders.
    Hadzhieva M; Kirches E; Mawrin C
    Neuropathol Appl Neurobiol; 2014 Apr; 40(3):240-57. PubMed ID: 24164678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint.
    Kaindlstorfer C; Jellinger KA; Eschlböck S; Stefanova N; Weiss G; Wenning GK
    J Alzheimers Dis; 2018; 61(4):1253-1273. PubMed ID: 29376857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer's and Parkinson's disease models.
    Feng ST; Wang ZZ; Yuan YH; Sun HM; Chen NH; Zhang Y
    Pharmacol Res; 2019 Aug; 146():104336. PubMed ID: 31271846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dementia means number of things - the overlap of neurodegeneration with brain iron accumulation (NBIA) and Alzheimer changes: an autopsy case.
    Dziewulska D; Domitrz I; Domzał-Stryga A
    Folia Neuropathol; 2010; 48(2):129-33. PubMed ID: 20602294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.
    Jellinger KA
    Drugs Aging; 1999 Feb; 14(2):115-40. PubMed ID: 10084365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron in neurodegenerative disorders: being in the wrong place at the wrong time?
    Apostolakis S; Kypraiou AM
    Rev Neurosci; 2017 Nov; 28(8):893-911. PubMed ID: 28792913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.